MicroRNA expression linked to neoadjuvant chemo response

June 16, 2014
MicroRNA expression linked to neoadjuvant chemo response

(HealthDay)—Expression of the microRNA MiR-193a-5p, together with HGF and c-MET proteins, is associated with response to neoadjuvant chemotherapy (NACT) in ovarian cancer, according to a study published online June 13 in Oncotarget.

Marisa Mariani, Ph.D., from the Danbury Hospital Research Institute in Connecticut, and colleagues attempted to identify actionable mechanisms of resistance to NACT in patients with . MicroRNA expression was screened in a set of 85 patients. To analyze potential targets, significant correlations were calculated between microRNAs and genes. In a validation set of 109 patients, quantitative immunohistochemistry was employed to validate targets.

The researchers found that in the NACT setting, MiR-193a-5p was significantly overexpressed. This microRNA was also significantly correlated with HGF and MET genes in analysis of potential targets. In analysis of before and after NACT, both HGF and MET were found to be increased after NACT. The highest relative basal expression of HGF and c-MET was exhibited by patients who relapsed shortly after NACT, while the opposite phenomenon was seen in the best responders.

"Mir-193a-5p, HGF, and c-Met expression may help select eligible for this modality of treatment," the authors write. "Moreover, inhibitors of this pathway may improve the efficacy of NACT."

Explore further: Circulating MicroRNAs linked to type 2 diabetes

More information: Abstract
Full Text

Related Stories

Circulating MicroRNAs linked to type 2 diabetes

February 7, 2014
(HealthDay)—Circulating microRNAs (miRNAs) are associated with type 2 diabetes (T2D), and their levels vary with insulin action, according to a study published online Jan. 29 in Diabetes Care.

Serum miR-21 putative biomarker for colorectal cancer

June 20, 2013
(HealthDay)—The oncogenic microRNA (miRNA) miR-21 is a potential biomarker for detection and prognosis of colorectal cancer (CRC), according to a study published in the June 19 issue of the Journal of the National Cancer ...

Team finds microRNA that could be used to suppress prostate cancer progression

May 16, 2014
About one in seven men will develop prostate cancer over the course of a lifetime, and about one in 36 men will die from it.

Discovery predicts patient sensitivity to important drug target in deadly brain cancer

February 6, 2012
A recent discovery by Van Andel Research Institute (VARI) scientists enables the prediction of patient sensitivity to proposed drug therapies for glioblastoma – the most common and most aggressive malignant brain tumor ...

Researchers discover ovarian cancer biomarker

January 8, 2014
Researchers at Case Western Reserve University have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer – a breakthrough that has the potential to ...

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.